Stage 2 · Toolkit 2.11
Nonclinical Report Review & Submission Package
Review, QC, organise, and trace nonclinical reports for IND/CTA/CTD use.
What it helps control
Operational support
Helps teams establish the procedures, working records, trackers, and evidence needed for Nonclinical Report Review & Submission Package.
How it helps your team
Surface evidence gaps and dependencies before they delay IND, CTA, or first-in-human decisions.
Designed for
Nonclinical development, toxicology, safety pharmacology, bioanalysis, Regulatory Affairs, and Quality teams.
Included files
Know exactly what the toolkit contains
The file names below show what is included. File contents become available only after purchase.
Word documents
- Nonclinical Report Review SOP
- Nonclinical Study Report Template
- Nonclinical Report QC Checklist
- Nonclinical Submission Summary Template
- Nonclinical Evidence Traceability Guide
- Nonclinical Report Decision Memo
Excel workbooks
- Nonclinical Report Tracker
- Report Comment Tracker
- Submission Evidence Matrix
- Nonclinical Finding Summary Tracker
- Report Readiness Tracker
Related toolkits
Continue within stage 2
Nonclinical Development Plan & IND/CTA-Enabling Strategy
Define the nonclinical package needed to support IND, CTA, first-in-human, and clinical development.
2.2GLP Compliance & Sponsor Oversight
Ensure GLP studies are appropriately planned, overseen, monitored, documented, reported, and archived.
2.3Toxicology Study Planning & Management
Manage toxicology studies and interpret key findings for regulatory and FIH readiness.